Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter ...

Government initiatives continue to play a central role in driving the MMR vaccine market growth. In February 2025, the New ...

The PGIM Jennison Growth Fund returned - $10.0%, matching the Russell 1000 Growth Index, which also returned -10.0% in Q1 ...

The PGIM Jennison Focused Growth Fund fell -11.7%, underperforming the Russell 1000 Growth Index, which fell 10.0%. Click ...

The Global Neurostimulation Devices revenue was USD 8212 Million in 2024 and is forecast to a readjusted size of USD 17200 Million by 2031 with a CAGR of 11.3% during the forecast period (2024-2031).